Cellectis SA

Cellectis SA (CLLS) Price Prediction & Forecast

$3.300

-0.049 (-1.49%)At close

Price Predictions

1-Day Price Prediction
+0.74%
1-Week Prediction
+0.57%
1-Month Prediction
2026 Prediction
2030 Prediction

Open in app to unlock longer-horizon forecasts.

Loading chart…

CLLS Prediction & Forecast by Similar Chart Analysis

Alphio's CLLS stock price prediction model matches the current Cellectis SA tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.32 (+0.74%). The 1-week path is $3.32 (+0.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Cellectis SA Stock?

Cellectis SA is a good buy right now due to its recent FDA RMAT designation for its CAR-T therapy, which has shown a 67% objective response rate in trials. The current price of $3.40 is significantly lower than the analyst price target of $9, suggesting substantial upside potential. Additionally, the stock has gained 23.64% over the last 20 days, indicating positive momentum. However, the forward P/E ratio is 0, reflecting uncertainty in earnings projections, which is a risk to consider.

CLLS stock price ended at $3.30 on Tuesday, after losing -1.49%

Cellectis SA (CLLS) last closed at $3.3, losing -1.49%. These facts feed the 1-day and 1-week CLLS price prediction above.

Analyst Consensus

Cellectis SA (CLLS): 5 buy, 1 hold, 0 sell. Outlook: Strong Buy.

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong sellSellNeutralBuyStrong buy
Strong buy
Sell
0
Buy
5

Forecast Drivers

Cellectis SA (CLLS) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

Similar Chart Patterns

Stocks whose recent price path most closely matches CLLS, ranked by similarity.

Seasonality analysis for CLLS

Historically the probability of a positive September return for CLLS is 50.00%. December offers the highest probability of a positive month at 51.16%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for CLLS

MonthMin PriceAvg PriceMax PricePotential ROI
Sep 2026$1.19$2.46$3.34-25.31%
Oct 2026$2.83$4.13$4.90+25.02%
Nov 2026$1.87$2.70$3.82-18.13%
Dec 2026$0.74$2.46$3.65-25.41%

In 2026, Cellectis SA (CLLS) is projected to range from $0.74 to $4.90.

Cellectis SA 2026 monthly forecast

Sep 2026 CLLS forecast
Potential ROI: -25.31%

In Sep 2026, Cellectis SA is projected to average $2.46, with a low of $1.19 and high of $3.34.

Oct 2026 CLLS forecast
Potential ROI: 25.02%

In Oct 2026, Cellectis SA is projected to average $4.13, with a low of $2.83 and high of $4.90.

Nov 2026 CLLS forecast
Potential ROI: -18.13%

In Nov 2026, Cellectis SA is projected to average $2.70, with a low of $1.87 and high of $3.82.

Dec 2026 CLLS forecast
Potential ROI: -25.41%

In Dec 2026, Cellectis SA is projected to average $2.46, with a low of $0.74 and high of $3.65.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started